Related Practice Life Sciences & Pharma Immuno-oncology has significant diagnostic needs including identifying patients most likely to respond to therapies. 08012019170843
Published Articles Sustainability To Meet Decarbonization Targets, Master The Circular Economy July 9, 2024
Case Study Life Sciences & Pharma Cost and Reimbursement Assessment for a Biopharmaceutical Company May 7, 2024 A large biopharmaceutical company developing chimeric antigen receptor T-cell (CAR-T) therapies
Case Study Biotech and Pharmaceuticals Late Lifecycle Strategy Assessment for a Biologic April 30, 2024
Executive Insights Diagnostics, Tools and Personalized Medicine Autologous Cell Therapy: Key Challenges and Bioprocessing Innovations February 7, 2024
Article Life Sciences & Pharma The SEA Healthcare, Medtech, and Pharma Landscape in 2023 December 7, 2023
Executive Insights Life Sciences & Pharma EUnetHTA 21 — Transition to EU-wide HTAs: Implications for Pharma July 31, 2023